- Home
- TLF vs VYNE Comparison
TLF vs VYNE Comparison
Compare TLF & VYNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TLF
- VYNE
- Stock Information
- Founded
- TLF 1980
- VYNE 2003
- Country
- TLF United States
- VYNE United States
- Employees
- TLF N/A
- VYNE N/A
- Industry
- TLF Apparel
- VYNE Biotechnology: Pharmaceutical Preparations
- Sector
- TLF Consumer Discretionary
- VYNE Health Care
- Exchange
- TLF Nasdaq
- VYNE Nasdaq
- Market Cap
- TLF 42.8M
- VYNE 35.7M
- IPO Year
- TLF N/A
- VYNE 2018
- Fundamental
- Price
- TLF $3.86
- VYNE $2.74
- Analyst Decision
- TLF
- VYNE Strong Buy
- Analyst Count
- TLF 0
- VYNE 2
- Target Price
- TLF N/A
- VYNE $6.88
- AVG Volume (30 Days)
- TLF 59.9K
- VYNE 86.1K
- Earning Date
- TLF 03-21-2025
- VYNE 03-07-2025
- Dividend Yield
- TLF N/A
- VYNE N/A
- EPS Growth
- TLF 5.05
- VYNE N/A
- EPS
- TLF 0.29
- VYNE N/A
- Revenue
- TLF $74,758,000.00
- VYNE $493,000.00
- Revenue This Year
- TLF N/A
- VYNE $28.30
- Revenue Next Year
- TLF N/A
- VYNE N/A
- P/E Ratio
- TLF $13.43
- VYNE N/A
- Revenue Growth
- TLF N/A
- VYNE 39.27
- 52 Week Low
- TLF $3.53
- VYNE $1.57
- 52 Week High
- TLF $5.48
- VYNE $4.30
- Technical
- Relative Strength Index (RSI)
- TLF 30.62
- VYNE 56.12
- Support Level
- TLF $3.53
- VYNE $2.39
- Resistance Level
- TLF $4.20
- VYNE $2.65
- Average True Range (ATR)
- TLF 0.20
- VYNE 0.20
- MACD
- TLF -0.14
- VYNE 0.05
- Stochastic Oscillator
- TLF 16.92
- VYNE 71.01
About TLF Tandy Leather Factory Inc.
Tandy Leather Factory Inc is a specialty retailers of leather and leathercraft-related items. Its primary line of business is the sale of leather, leather crafts, and related supplies. Its broad line of leather and related products includes leather, leatherworking tools, leather dyes and finishes, and do-it-yourself kits. Its products include Leather, tools, Hardware, Supplies, Kits, Books and Patterns, and Gift cards. The company sells its products primarily through company-owned stores and through orders generated from its global websites, and through direct account representatives in its commercial division. Geographically the company operates within the United States, Canada and others and generates the highest revenue from the United States.
About VYNE VYNE Therapeutics Inc.
VYNE Therapeutics Inc is a biopharmaceutical company focused on developing proprietary, innovative and differentiated therapies for the treatment of immuno-inflammatory conditions. Its advanced product candidate is FMX114, which is being evaluated for the potential treatment of mild-to-moderate AD (atopic dermatitis). The company is also in the pre-clinical stages of developing products containing BET (Bromodomain and Extra-Terminal Domain) inhibitor compounds. Its products include AMZEEQ, ZILXI, and FCD105.